Analytic Investors’s AbbVie ABBV Stock Holding History

Analytic Investors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$34.8M	Buy	551,753 +328,919	+148%	+$21.3M	0.39%	70
2016 Q2	$13.8M	Sell	222,834 -63,330	-22%	-$3.86M	0.16%	122
2016 Q1	$16.3M	Buy	+286,164	New	+$15.9M	0.2%	120
2015 Q2	–	Sell	-118,123	Closed	-$6.92M	–	558
2015 Q1	$6.92M	Buy	118,123 +113,654	+2,543%	+$6.87M	0.09%	151
2014 Q4	$292K	Sell	4,469 -134,874	-97%	-$8.5M	﹤0.01%	477
2014 Q3	$8.05M	Sell	139,343 -387,453	-74%	-$21.5M	0.12%	149
2014 Q2	$29.7M	Buy	526,796 +175,535	+50%	+$9.21M	0.48%	60
2014 Q1	$18.1M	Sell	351,261 -182,342	-34%	-$9.22M	0.27%	97
2013 Q4	$28.2M	Sell	533,603 -161,097	-23%	-$7.92M	0.47%	65
2013 Q3	$31.1M	Sell	694,700 -210,480	-23%	-$9.33M	0.5%	58
2013 Q2	$37.4M	Buy	+905,180	New	+$39.6M	0.62%	44

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Analytic Investors's ABBV Position: Q3 2016 in Review

Analytic Investors increased its AbbVie (ABBV) stake by 148% in Q3 2016, buying an estimated $21.3M and bringing the position to 551,753 shares worth $34.8M. The position accounts for 0.39% of the portfolio, ranked #70.

Analytic Investors first reported a position in ABBV in Q2 2013 and has held it in 11 quarters since. The position peaked at $37.4M in Q2 2013. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

Analytic Investors held 551,753 shares of AbbVie worth $34.8M as of Q3 2016.
Analytic Investors bought 328,919 AbbVie shares in Q3 2016, an estimated $21.3M.
AbbVie made up 0.39% of Analytic Investors's portfolio in Q3 2016, its #70 holding.
Analytic Investors first reported a position in AbbVie in Q2 2013 and has held it in 11 quarters since.
Analytic Investors's AbbVie position peaked at $37.4M in Q2 2013.
1,653 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.